4.3 Article

NADPH oxidase mediates TNF-α-evoked in vitro brain barrier dysfunction: roles of apoptosis and time

期刊

MOLECULAR AND CELLULAR NEUROSCIENCE
卷 61, 期 -, 页码 72-84

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.mcn.2014.06.002

关键词

TNF-alpha; Blood-brain barrier; NADPH oxidase; MMP; Cytoskeleton

资金

  1. PhD studentship grant

向作者/读者索取更多资源

The pro-inflammatory cytokine TNF-alpha severely perturbs the integrity of the blood-brain barrier (BBB). This study explored the specific roles of NADPH oxidase and associated downstream effectors by using human brain microvascular endothelial cells (HBMECs) and human astrocytes (HAs), the key components of BBB, alone or in co-cultures to mimic human BBB. Exposure to TNF-alpha (6 h) impaired BBB integrity as evidenced by marked decreases in transendothelial electrical resistance and concurrent increases in paracellular flux which appeared to subside with time (24 h). Increased barrier dysfunction concurred with increases in endothelial NADPH oxidase activity, O-2(center dot-) production, actin stress fibre formation, MMP-2/9 activities and concomitant decreases in antioxidant (CuZn-SOD and catalase) and tight junction (claudin-5 and occludin) protein expressions. Conversely, TNF-alpha did not affect astrocytic MMP activities and antioxidant enzyme expressions. Unlike BBB damage, rates of HBMEC and HA apoptosis increased by time. Suppression of NADPH oxidase by apocynin or diphenyleneiodonium prevented TNF-alpha-evoked morphological changes and apoptosis, attenuated endothelial MMP activity and helped retain usual tight junction protein expression and barrier function. In conclusion, HBMECs constitute the main source of oxidative stress and basement-membrane degrading endopeptidases in inflammatory conditions associated with excessive release of TNF-alpha where targeting NADPH oxidase may prove extremely beneficial in maintaining proper barrier activity through prevention of cytoskeletal and tight junction reorganisations. (C) 2014 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Neurosciences

Inhibition of TNF-α protects in vitro brain barrier from ischaemic damage

Zuraidah Abdullah, Kamini Rakkar, Philip M. W. Bath, Ulvi Bayraktutan

MOLECULAR AND CELLULAR NEUROSCIENCE (2015)

Article Biochemistry & Molecular Biology

Suppression of PKC-α attenuates TNF-α-evoked cerebral barrier breakdown via regulations of MMP-2 and plasminogen-plasmin system

Zuraidah Abdullah, Ulvi Bayraktutan

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)

Article Biochemistry & Molecular Biology

Increases in intracellular calcium perturb blood-brain barrier via protein kinase C-alpha and apoptosis

Kamini Rakkar, Ulvi Bayraktutan

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)

Article Endocrinology & Metabolism

Hyperglycaemia promotes cerebral barrier dysfunction through activation of protein kinase C-β

B. Shao, U. Bayraktutan

DIABETES OBESITY & METABOLISM (2013)

Article Endocrinology & Metabolism

PKC-β exacerbates in vitro brain barrier damage in hyperglycemic settings via regulation of RhoA/Rho-kinase/MLC2 pathway

Kirtiman Srivastava, Beili Shao, Ulvi Bayraktutan

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2013)

Article Biochemistry & Molecular Biology

inhibition of rho kinase protects cerebral barrier from ischaemia-evoked injury through modulations of endothelial cell oxidtive stress and tight junctions

Claire L. Gibson, Kirtiman Srivastava, Nikola Sprigg, Philip M. W. Bath, Ulvi Bayraktutan

JOURNAL OF NEUROCHEMISTRY (2014)

Review Neurosciences

Epidemiology, Pathophysiology, and Treatment of Hypertension in Ischaemic Stroke Patients

Nur Fatirul Hisham, Ulvi Bayraktutan

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2013)

Review Pharmacology & Pharmacy

Endothelial progenitor cells: Potential novel therapeutics for ischaemic stroke

Ulvi Bayraktutan

PHARMACOLOGICAL RESEARCH (2019)

Review Cell Biology

Urokinase Plasminogen Activator: A Potential Thrombolytic Agent for Ischaemic Stroke

Rais Reskiawan A. Kadir, Ulvi Bayraktutan

CELLULAR AND MOLECULAR NEUROBIOLOGY (2020)

暂无数据